Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome

Science Immunology(2020)10.1126/sciimmunol.abe0240Source: DataRank Database

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome is a research paper published in Science Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 508 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access508 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 11.05)OA: hybridTopics (48)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (30)

Abigail E. Powell ORCID,Oliver F. Wirz ORCID,Bryan Stevens ORCID,Catherine A. Hogan ORCID,Javaria Najeeb ORCID

Live enrichment

PubMed:33288645 PMC:PMC7857392 OpenAlex:https://openalex.org/W3111459703

National Institutes of Health

Grant: 1U54CA260517

National Institute of Allergy and Infectious Diseases

Grant: T32 AI007502-23

Stanford Maternal and Child Health Research Institute

Grant: Postdoctoral Fellowship

Swiss National Science Foundation

Grant: Early Postdoc.Mobility Fellowship

NIH/NIAID

Grant: R01AI127877

NIH/NIAID

Grant: R01AI130398

Crown Family Foundation

Grant: endowment

NIAID NIH HHS

Grant: U19 AI111825

NIAID NIH HHS

Grant: T32 AI007502

NCI NIH HHS

Grant: U54 CA260517

NCATS NIH HHS

Grant: UL1 TR003142

FWCI

11.05

Citation Percentile

1.0%

Citation Trend

2014

2020

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://www.science.org/doi/pdf/10.1126/sciimmunol.abe0240?download=true

publisherhttps://www.science.org/doi/pdf/10.1126/sciimmunol.abe0240?download=true

publisherhttps://syndication.highwire.org/content/doi/10.1126/sciimmunol.abe0240

publisherhttps://www.science.org/doi/pdf/10.1126/sciimmunol.abe0240

journalhttps://doi.org/10.1126/sciimmunol.abe0240

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testingAdultAgedAged, 80 and overAngiotensin-Converting Enzyme 2Antibodies, NeutralizingAntibodies, ViralCOVID-19Enzyme-Linked Immunosorbent AssayFemaleHumansMaleMiddle AgedReal-Time Polymerase Chain ReactionSARS-CoV-2Severity of Illness IndexSpike Glycoprotein, Coronavirus

MeSH Terms

Angiotensin-Converting Enzyme 2COVID-19SARS-CoV-2AdultAgedAged, 80 and overAntibodies, ViralEnzyme-Linked Immunosorbent AssayFemaleHumansMaleMiddle AgedSeverity of Illness IndexAntibodies, NeutralizingReal-Time Polymerase Chain ReactionSpike Glycoprotein, Coronavirus

Keywords

DiseaseAntibodyDuration (music)ImmunologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineCoronavirus disease 2019 (COVID-19)Outcome (game theory)Antibody responseVirologyBiologyInternal medicineInfectious disease (medical specialty)

Sustainable Development Goals

SDG 0: Good health and well-being